News & Research

Loading...

Fundswire

Loading...

Asset Classes A-Z
View funds in this asset class

News & Research

PIMCO

Why this top multi-asset fund has halved its bond allocation since 2022

Jonathan Jones
10 March 2026
The managers have turned back to alternative assets.

Making hay in the sunshine as biotech’s outlook brightens

Ailsa Craig and Marek Poszepczynski
10 March 2026
After a turbulent 2025, the International Biotechnology Trust managers see improving M&A activity, stronger financing markets and a more pragmatic FDA as reasons for optimism.

Performance Tables

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.